![](/img/cover-not-exists.png)
PMS53 UTILISATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN QUEBEC, CANADA: IS THERE A CHANGE IN THE PATIENT RISK PROFILE AFTER THE WITHDRAWAL OF ROFECOXIB?
E Rahme, JP Roussy, JP Lafrance, H Nedjar, S MorinVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(10)72639-5
File:
PDF, 76 KB
english, 2010